Tivic Health Systems, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Murchinson Ltd. and its affiliated entities have reported beneficial ownership of 9.99% of Valion Bio, Inc.'s common stock, primarily through Series C preferred stock conversion rights.
NASDAQ
3i, LP and associated entities have filed an amendment to their Schedule 13G, disclosing a 9.9% beneficial ownership stake in Valion Bio, Inc.
NASDAQ
A group of investors, including 3i, LP and Tumim Stone Capital LLC, has increased its beneficial ownership in Tivic Health Systems, Inc. to 9.9% by adjusting beneficial ownership limitations.